Skip to content

Repaglinide

Repaglinide (Prandin) appears in one listed tablet product, Prandin. The Antidiabetic classification provides context for its listed use for Type 2 Diabetes Mellitus. Product details identify the specific presentation and ingredient composition, while the catalogue brings its stated strength and formulation together for comparison.

Prandin

Type 2 Diabetes Mellitus

0.5mg · 1mg · 2mg

Indicated to address postprandial glycaemic elevations to manage type 2 diabetes and support mealtime insulin release.

From$1.67/ tabletView

What is Repaglinide used for?

One listed use is Type 2 Diabetes Mellitus. Related medicines appear within Diabetes Management.

Important safety information for Repaglinide

Information about Repaglinide on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.